Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 7/20 | 0.47 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.47 |
| ▸ | CES2 | O00748 | 1/20 | 0.47 |
| ▸ | SCN5A | Q14524 | 3/20 | 0.45 |
| ▸ | SCN9A | Q15858 | 3/20 | 0.45 |
| ▸ | GGPS1 | O95749 | 3/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28100654 | 1.00 | FDPS (0.47) | FDPSSMPD1CES2SCN5ASCN9A | |
| SCHEMBL28052087 | 1.00 | FDPS (0.47) | FDPSSMPD1CES2SCN5ASCN9A | |
| SCHEMBL10896548 | 1.00 | FDPS (0.47) | FDPSSMPD1CES2SCN5ASCN9A | |
| SCHEMBL27527657 | 1.00 | FDPS (0.47) | FDPSSMPD1CES2SCN5ASCN9A | |
| SCHEMBL31472765 | 1.00 | FDPS (0.47) | FDPSSMPD1CES2SCN5ASCN9A | |
| SCHEMBL18641723 | 1.00 | FDPS (0.47) | FDPSSMPD1CES2SCN5ASCN9A | |
| SCHEMBL29180319 | 1.00 | FDPS (0.47) | FDPSSMPD1CES2SCN5ASCN9A | |
| SCHEMBL20954037 | 1.00 | FDPS (0.47) | FDPSSMPD1CES2SCN5ASCN9A | |
| SCHEMBL20510878 | 1.00 | FDPS (0.47) | FDPSSMPD1CES2SCN5ASCN9A | |
| SCHEMBL31289080 | 0.98 | FDPS (0.45) | FDPSSMPD1CES2SCN5ASCN9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026102260-A1 | CRISPR-RELATED METHODS AND COMPOSITIONS TARGETING ANGIOPOIETIN LIKE 3 (ANGPTL3) | EDITAS MEDICINE, INC. (US) | 2026-05-15 | — | — | WO | disclosed |
| EP-4705275-A1 | LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS | Acuitas Therapeutics, Inc. (CA) | 2026-03-11 | — | — | EP | disclosed |
| WO-2024233387-A1 | LIPIDS FOR USE IN LIPID NANOPARTICLE FORMULATIONS | Acuitas Therapeutics, Inc. (CA) | 2024-11-14 | — | — | WO | disclosed |
| CN-105971571-B | Method and composition for oil well and/or gas well | 弗洛泰克化学有限责任公司 | 2019-10-15 | — | — | CN | disclosed |
| CN-106837217-B | For oil well and/or the composition and method comprising terpenol of gas well | 弗洛泰克化学有限责任公司 | 2019-07-02 | — | — | CN | disclosed |
| CN-105419750-B | Method and composition for oil well and/or gas well | 弗洛泰克化学有限责任公司 | 2019-03-22 | — | — | CN | disclosed |
| CN-106837217-A | For oil well and/or the composition comprising terpenol and method of gas well | 弗洛泰克化学有限责任公司 | 2017-06-13 | — | — | CN | disclosed |
| CN-105971571-A | Methods and compositions for use in oil and/or gas wells | CESI化工有限公司 | 2016-09-28 | — | — | CN | disclosed |